Table 3.
TAV-in-TAV registries.
| Redo TAVR registry (23) | Transit registry (24) | Global REDO-TAVI (25) | TVT 2021 (26) Sapien platform |
TVT registry 2022 (27) Evolut platform |
National registry 2023 (28) BEV |
|
|---|---|---|---|---|---|---|
| Number of patients | 138 | 172 | 165 | 591 | 292 | 1,320 |
| Mean age, years | 79.2 | 79.9 | 80 | 78.5 | 78.6 | 78 |
| STS risk score, % | 6.9 | 6.1 | 6.83 | 8.9 | 10.4 | |
| Indication for TAV-in-TAV | Mainly SVD | SVD | SVD | Mainly SVD | ||
| Index THV failure mode | AS: 37% AR: 29.7% Combined: 32.6% |
AS: 33% AR: 56% Combined: 11% |
AS: 34.5 AR: 35.2 Combined: 29.7 |
AS: 44% AR: 62.1% |
||
| Device success, % | 85.5 | 79.7 | 94.5 | |||
| Post procedural mean gradient, mmHg | 12.6 | 10.9 | 14.6 | 11.9 | ||
| 30-day mortality, % | 1.4 | 7 | 3 | 4.9 | 3.2 | 4.7 |
| 1 year mortality, % | 11.7 | 10 | 11.9 | 15.6 | 17.7 | 17.5 |
| 30-day stroke, % | 0.7 | 3.5 | 0.6 | 2.4 | 3.1 | 2 |
| Coronary obstruction, % | 0.7 | 0 | 1.2 | 0.5 | 0 | 0.3 |